2,269
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Lipid composition has significant effect on targeted drug delivery properties of NGR-modified liposomes

, , , , &
Pages 1426-1433 | Received 14 Jul 2015, Accepted 26 Aug 2015, Published online: 16 Sep 2015

Figures & data

Table 1. Characterization of coumarin-6 liposomes with different PC composition (n = 3).

Figure 1. The flow cytometric measurement of coumarin-6 uptake from NGR-SL-C-HS and SL-C-HS by HT1080 (CD13+) cells at the time of 1 h. Cells were incubated with NGR-SL-C-HS and SL-C-HS at the final coumarin-6 concentration of 100 ng/mL, and the time point of 1 h, the cells were trypsinized, washed and analyzed using flow cytometry. 1 – Control, 2 – SL-C-HS, 3 – NGR+NGR-SL-C-HS, 4 – NGR-SL-C-HS.

Figure 1. The flow cytometric measurement of coumarin-6 uptake from NGR-SL-C-HS and SL-C-HS by HT1080 (CD13+) cells at the time of 1 h. Cells were incubated with NGR-SL-C-HS and SL-C-HS at the final coumarin-6 concentration of 100 ng/mL, and the time point of 1 h, the cells were trypsinized, washed and analyzed using flow cytometry. 1 – Control, 2 – SL-C-HS, 3 – NGR+NGR-SL-C-HS, 4 – NGR-SL-C-HS.

Figure 2. The flow cytometric measurement of coumarin-6 uptake from NGR-SL-C-HS, NGR-SL-C-S, NGR-SL-C-H and NGR-SL-C-D by HT1080 (CD13+) cells at the time of 1 h. Cells were incubated with liposomes at the final coumarin-6 concentration of 100 ng/mL. And the time point of 1 h, the cells were trypsinized, washed and analyzed using flow cytometry. 1 – Control, 2 – NGR-SL-C-D, 3 – NGR -SL-C-H, 4 – NGR-SL-C-HS, 5 – NGR-SL-C-S.

Figure 2. The flow cytometric measurement of coumarin-6 uptake from NGR-SL-C-HS, NGR-SL-C-S, NGR-SL-C-H and NGR-SL-C-D by HT1080 (CD13+) cells at the time of 1 h. Cells were incubated with liposomes at the final coumarin-6 concentration of 100 ng/mL. And the time point of 1 h, the cells were trypsinized, washed and analyzed using flow cytometry. 1 – Control, 2 – NGR-SL-C-D, 3 – NGR -SL-C-H, 4 – NGR-SL-C-HS, 5 – NGR-SL-C-S.

Figure 3. The confocal microscopy images of HT1080 (CD13+) and HCAEC (CD13) incubated with different coumarin-6 liposomes for 1 h at 37 °C. Green represents fluorescence of coumarin-6, blue represents fluorescence of Hoechst 33258. (For interpretation of the reference to color in this figure legend, the reader is referred to the web version of this article.)

Figure 3. The confocal microscopy images of HT1080 (CD13+) and HCAEC (CD13−) incubated with different coumarin-6 liposomes for 1 h at 37 °C. Green represents fluorescence of coumarin-6, blue represents fluorescence of Hoechst 33258. (For interpretation of the reference to color in this figure legend, the reader is referred to the web version of this article.)

Table 2. Characterization of brucine-loaded liposomes with different lipid composition (n = 3).

Figure 4. The release of brucine from NGR-SL-B with different lipid compositions and SL-B-HS incubated with fresh rat plasma at 37 °C (n = 3).

Figure 4. The release of brucine from NGR-SL-B with different lipid compositions and SL-B-HS incubated with fresh rat plasma at 37 °C (n = 3).

Figure 5. Cytotoxicity of brucine-loaded liposomes with different lipid composition and brucine solution. After the addition of brucine formulations (NGR-SL-B-HS, SL-B-HS, NGR-SL-B-S, NGR-SL-B-H, NGR-SL-B-D or brucine solution) to cells, the mixture was incubated for 48 h and the viability of HT1080 cells was measured by MTT assay.

Figure 5. Cytotoxicity of brucine-loaded liposomes with different lipid composition and brucine solution. After the addition of brucine formulations (NGR-SL-B-HS, SL-B-HS, NGR-SL-B-S, NGR-SL-B-H, NGR-SL-B-D or brucine solution) to cells, the mixture was incubated for 48 h and the viability of HT1080 cells was measured by MTT assay.

Figure 6. The ex vivo optical images of tumors and organs of HT1080 in tumor-bearing mice sacrificed at 20 h after NGR-SL-DiR with different lipid composition administration.

Figure 6. The ex vivo optical images of tumors and organs of HT1080 in tumor-bearing mice sacrificed at 20 h after NGR-SL-DiR with different lipid composition administration.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.